Literature DB >> 20535798

Exploring the public health impact of an intensive exercise program for patients with rheumatoid arthritis: a dissemination and implementation study.

F J van der Giesen1, W van Lankveld, M Hopman-Rock, Z de Jong, M Munneke, J M W Hazes, P L C M van Riel, A J Peeters, H K Ronday, T P M Vliet Vlieland.   

Abstract

OBJECTIVE: To evaluate the implementation of an intensive group exercise program in patients with rheumatoid arthritis (RA).
METHODS: In 4 regions in The Netherlands, the Rheumatoid Arthritis Patients In Training exercise program was implemented on a limited scale. Evaluation using the RE-AIM model included: Reach, the proportion of the target population participating; Efficacy, effects on muscle strength, aerobic capacity, functional ability, and psychological functioning; Adoption, program adoption by stakeholders; Implementation, intervention quality (quality audits); and Maintenance, stakeholders' willingness to continue the program in the future.
RESULTS: Twenty-five physical therapists from 14 practices were trained to provide the program. In total, 150 RA patients were recruited (by estimation, 2% of the target population). Of the 81 patients who had finished the 12-month intervention and were available for followup directly after the intervention, 62 patients provided clinical data. Muscle strength improved significantly, whereas aerobic capacity, functional ability, psychological functioning, and disease activity did not change. All 9 informed local patient organizations facilitated patient recruitment, and 35 of 51 rheumatologists involved referred one or more patients. All 10 approached health insurance companies funded the program for 12 months. The quality audits showed sufficient quality in 9 of 12 practices. All of the providers of the program were willing to provide the program in the future, whereas future reimbursement by health insurance companies remained unclear.
CONCLUSION: The implementation of an intensive exercise program for RA patients on a limited scale can be considered successful regarding its reach, adoption, and implementation. The limited effectiveness and the limited data regarding maintenance warrant additional research.

Entities:  

Mesh:

Year:  2010        PMID: 20535798     DOI: 10.1002/acr.20138

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  5 in total

1.  Diet and Rheumatoid Arthritis Symptoms: Survey Results From a Rheumatoid Arthritis Registry.

Authors:  Sara K Tedeschi; Michelle Frits; Jing Cui; Zhi Zack Zhang; Taysir Mahmoud; Christine Iannaccone; Tzu-Chieh Lin; Kazuki Yoshida; Michael E Weinblatt; Nancy A Shadick; Daniel H Solomon
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-12       Impact factor: 4.794

2.  Putting the Dissemination and Implementation in Infectious Diseases.

Authors:  Jason P Burnham; Elvin Geng; Chinmayi Venkatram; Graham A Colditz; Virginia R McKay
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

3.  Recommendations and the state of the evidence for physical activity interventions for adults with rheumatoid arthritis: 2007 to present.

Authors:  Maura D Iversen; Marisa Brawerman; Christina N Iversen
Journal:  Int J Clin Rheumtol       Date:  2012-10-01

Review 4.  Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  James M Gwinnutt; Maud Wieczorek; Giulio Cavalli; Andra Balanescu; Heike A Bischoff-Ferrari; Annelies Boonen; Savia de Souza; Annette de Thurah; Thomas E Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja Stamm; Karen Walker-Bone; Joep Welling; Mirjana I Zlatković-Švenda; Francis Guillemin; Suzanne M M Verstappen
Journal:  RMD Open       Date:  2022-03

5.  [Association of physical activity with fatigue and functional capacity in patients with rheumatoid arthritis].

Authors:  S Beider; S Flohr; S Gehlert; T Witte; D Ernst
Journal:  Z Rheumatol       Date:  2021-03       Impact factor: 1.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.